PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)
$1.52 0.24 (18.75%)
Analysed PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) News Sources
5 Must-Read Analyst Questions From PacBio’s Q2 Earnings Call
14-08-2026
yahoo.com
PacBio Cuts Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity
16-08-2026
marketbeat.com
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
24-08-2026
yahoo.com
Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here’s Who’s Best Positioned.
25-08-2026
247wallst.com
Pacific Biosciences of California, Inc. Q2 2026 Earnings Call Summary
04-08-2026
moby.co
PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system
05-08-2026
yahoo.com
Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market
20-07-2026
yahoo.com
Pacific Biosciences of California (PACB) Laps the Stock Market: Here's Why
28-07-2026
yahoo.com
PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings
05-08-2026
yahoo.com
Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates
05-08-2026
yahoo.com
What is the current price of PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)?
The current price of PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) is $1.52.
PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) absolute price change since previous trading day?
The absolute price change of PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) since the previous trading day is $0.24.
PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) percentage price change since previous trading day?
The percentage price change of PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) since the previous trading day is 18.75%.
What is the most recent average sentiment score for PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)?
The most recent average sentiment score for PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) is 53 out of 100.
What is the most recent average sentiment for PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)?
The most recent sentiment for PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) is .
SEC-8K** Filing Available For PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.